Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy.

Zhu, Jianshu; Fan, Jiawei; Xia, Yuanliang; Wang, Hengyi; Li, Yuehong; Feng, Zijia; Fu, Changfeng

Zhu, Jianshu; Fan, Jiawei; Xia, Yuanliang; Wang, Hengyi; Li, Yuehong; Feng, Zijia; Fu, Changfeng.

Afiliação

Zhu J; Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.
Fan J; Department of Gastroenterology, The First Hospital of Jilin University, Changchun, China.
Xia Y; Department of Cardiac Surgery, The First Hospital of Jilin University, Changchun, China.
Wang H; Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.
Li Y; Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.
Feng Z; Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.
Fu C; Department of Spine Surgery, The First Hospital of Jilin University, Changchun, China.

Front Pharmacol ; 14: 1271321, 2023.

Article em En | MEDLINE | ID: mdl-37808190

Palavras-chave

immunotherapy; myeloid cells; nanomedicine systems; osteosarcoma; tumor immune microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China